VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BigKNY3 who wrote (6866)	4/12/1998 6:06:00 PM
From: VLAD	Read Replies (1) of 23519

BigKNY3, In retrospect we can all say that the direct to consumer advertising did not appear to be worth the money spent. On the other hand, and in all fairness to management, what would everybody be saying if they had not advertised at all and the numbers were lower rather than flat? I think most would be complaining that since management did not advertise they stink. For what it is worth, I was told by Nina at vivus that the advertising research expected the best results to show up in May. Now the question is, if that is the case since Pfizer will be running at full steam in May won't this probably be the worse month for MUSE in regards to competition from Viagra? Perhaps Vivus management really not as dumb as first impressions may indicate. Perhaps Vivus management realized that Viagra would be out in full force in May and it would adversely effect MUSE sales in this particular month. Perhaps then, the timing of the advertising ie February through March was planned so that the May sales impact on MUSE would not be as severe than if no advertising occured. What do you think? VLAD

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next